523 related articles for article (PubMed ID: 15603816)
21. Novel porous hydroxyapatite prepared by combining H2O2 foaming with PU sponge and modified with PLGA and bioactive glass.
Huang X; Miao X
J Biomater Appl; 2007 Apr; 21(4):351-74. PubMed ID: 16543281
[TBL] [Abstract][Full Text] [Related]
22. Preparation and properties of poly(lactide-co-glycolide) (PLGA)/ nano-hydroxyapatite (NHA) scaffolds by thermally induced phase separation and rabbit MSCs culture on scaffolds.
Huang YX; Ren J; Chen C; Ren TB; Zhou XY
J Biomater Appl; 2008 Mar; 22(5):409-32. PubMed ID: 17494961
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
24. Development and characterization of a porous micro-patterned scaffold for vascular tissue engineering applications.
Sarkar S; Lee GY; Wong JY; Desai TA
Biomaterials; 2006 Sep; 27(27):4775-82. PubMed ID: 16725195
[TBL] [Abstract][Full Text] [Related]
25. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
[TBL] [Abstract][Full Text] [Related]
26. Effects of porosity and pore size on in vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering.
Wu L; Ding J
J Biomed Mater Res A; 2005 Dec; 75(4):767-77. PubMed ID: 16121386
[TBL] [Abstract][Full Text] [Related]
27. In vitro evaluation of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineering.
Jiang T; Abdel-Fattah WI; Laurencin CT
Biomaterials; 2006 Oct; 27(28):4894-903. PubMed ID: 16762408
[TBL] [Abstract][Full Text] [Related]
28. Polyurethane/poly(lactic-co-glycolic) acid composite scaffolds fabricated by thermally induced phase separation.
Rowlands AS; Lim SA; Martin D; Cooper-White JJ
Biomaterials; 2007 Apr; 28(12):2109-21. PubMed ID: 17258315
[TBL] [Abstract][Full Text] [Related]
29. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis.
Sung HJ; Meredith C; Johnson C; Galis ZS
Biomaterials; 2004 Nov; 25(26):5735-42. PubMed ID: 15147819
[TBL] [Abstract][Full Text] [Related]
30. Characterization of porous injectable poly-(propylene fumarate)-based bone graft substitute.
Kim CW; Talac R; Lu L; Moore MJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2008 Jun; 85(4):1114-9. PubMed ID: 17941027
[TBL] [Abstract][Full Text] [Related]
31. Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen.
Clark A; Milbrandt TA; Hilt JZ; Puleo DA
Acta Biomater; 2014 May; 10(5):2125-32. PubMed ID: 24424269
[TBL] [Abstract][Full Text] [Related]
32. Comparison of morphology and mechanical properties of PLGA bioscaffolds.
Leung L; Chan C; Baek S; Naguib H
Biomed Mater; 2008 Jun; 3(2):025006. PubMed ID: 18458364
[TBL] [Abstract][Full Text] [Related]
33. Poly(propylene fumarate) and poly(DL-lactic-co-glycolic acid) as scaffold materials for solid and foam-coated composite tissue-engineered constructs for cranial reconstruction.
Dean D; Topham NS; Meneghetti SC; Wolfe MS; Jepsen K; He S; Chen JE; Fisher JP; Cooke M; Rimnac C; Mikos AG
Tissue Eng; 2003 Jun; 9(3):495-504. PubMed ID: 12857417
[TBL] [Abstract][Full Text] [Related]
34. Anterior cruciate ligament regeneration using braided biodegradable scaffolds: in vitro optimization studies.
Lu HH; Cooper JA; Manuel S; Freeman JW; Attawia MA; Ko FK; Laurencin CT
Biomaterials; 2005 Aug; 26(23):4805-16. PubMed ID: 15763260
[TBL] [Abstract][Full Text] [Related]
35. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
36. The influence of architecture on degradation and tissue ingrowth into three-dimensional poly(lactic-co-glycolic acid) scaffolds in vitro and in vivo.
Cao Y; Mitchell G; Messina A; Price L; Thompson E; Penington A; Morrison W; O'Connor A; Stevens G; Cooper-White J
Biomaterials; 2006 May; 27(14):2854-64. PubMed ID: 16426678
[TBL] [Abstract][Full Text] [Related]
37. In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly(propylene fumarate)-diacrylate.
Timmer MD; Ambrose CG; Mikos AG
Biomaterials; 2003 Feb; 24(4):571-7. PubMed ID: 12437951
[TBL] [Abstract][Full Text] [Related]
38. Solvent effects on the microstructure and properties of 75/25 poly(D,L-lactide-co-glycolide) tissue scaffolds.
Sander EA; Alb AM; Nauman EA; Reed WF; Dee KC
J Biomed Mater Res A; 2004 Sep; 70(3):506-13. PubMed ID: 15293325
[TBL] [Abstract][Full Text] [Related]
39. Elastic biodegradable poly(glycolide-co-caprolactone) scaffold for tissue engineering.
Lee SH; Kim BS; Kim SH; Choi SW; Jeong SI; Kwon IK; Kang SW; Nikolovski J; Mooney DJ; Han YK; Kim YH
J Biomed Mater Res A; 2003 Jul; 66(1):29-37. PubMed ID: 12833428
[TBL] [Abstract][Full Text] [Related]
40. A dual-application poly (dl-lactic-co-glycolic) acid (PLGA)-chitosan composite scaffold for potential use in bone tissue engineering.
Boukari Y; Qutachi O; Scurr DJ; Morris AP; Doughty SW; Billa N
J Biomater Sci Polym Ed; 2017 Nov; 28(16):1966-1983. PubMed ID: 28777694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
